Eraxis
Active Ingredient(s): AnidulafunginFDA Approved: * February 17, 2006
Pharm Company: * VICURON
Category: Antifungal
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Eraxis Overview
Anidulafungin (INN)[1]:42 (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366.[3][4][5] It may also have application in treating invasive Aspergillus infection when used in combination with Voriconazole.[6] It is a member of the class of antifungal drugs known as the echinocandins; its mechanism of action is by inhibition of (1→3)-β...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Anidulafungin
Recent Eraxis Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Anidulafungin
- Injection: 100mg/vial, 50mg, 50mg/vial
- Powder: 100mg/vial, 50mg/vial
NDC Database Records for Eraxis: (2 results)
Sorted by National Drug Code- 0049-0114 Eraxis 50 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by Roerig
- 0049-0116 Eraxis 100 mg/30ml Intravenous Injection, Powder, Lyophilized, for Solution by Roerig